drugset / Trial / NCT05827484
The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this comparative study is to determine whether or not LOSARTAN with its anti-fibrotic action has an added effect when administrated with platelet rich plasma injection on skeletal muscle healing and on decreasing the fibrous scar after muscle injuries in comparison with the sole administration of platelet rich plasma.
Timeline
- Start
- 2016-10-10
- Primary completion
- 2017-09-05
- Completion
- 2017-12-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Autologous platelets rich plasma | Unknown | 3 ml | Other |
| Subject | Losartan | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.